PFG
GILD icon

Piershale Financial Group’s Gilead Sciences GILD Stock Holding History

Piershale Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-201
Closed -$17K – 159
2016
Q2 		$17K Buy
+201
New +$17.8K 0.01% 73
2016
Q1 		– Sell
-151
Closed -$15K – 160
2015
Q4 		$15K Buy
151
+1
+0.7% +$104 0.01% 88
2015
Q3 		$15K Sell
150
-50
-25% -$5.55K 0.01% 60
2015
Q2 		$23K Buy
+200
New +$21.9K 0.02% 46
2014
Q4 		– Sell
-338
Closed -$36K – 152
2014
Q3 		$36K Buy
+338
New +$33.1K 0.03% 45

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Piershale Financial Group's GILD Position: Q3 2016 in Review

Piershale Financial Group sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 201 shares — an estimated $17K sold.

Piershale Financial Group first reported a position in GILD in Q3 2014 and held it in 5 quarters. The position peaked at $36K in Q3 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Piershale Financial Group reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Piershale Financial Group sold 201 Gilead Sciences shares in Q3 2016, an estimated $17K.
  • Piershale Financial Group first reported a position in Gilead Sciences in Q3 2014 and held it in 5 quarters.
  • Piershale Financial Group's Gilead Sciences position peaked at $36K in Q3 2014.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Piershale Financial Group's 13F filing for Q3 2016, filed 18 Oct 2016.